HOME >> MEDICINE >> NEWS
Estrogen or stimulating environment boost memory

New Haven, Conn.--Estrogen treatment had less beneficial effect on memory in female mice that raced on running wheels and played with other toys than in mice raised in non-stimulating environments, according to a Yale study published this month.

"We saw no beneficial effect of estrogen in the animals in cognitively and physically stimulating environments (also known as enriched environments)," said Karyn Frick, assistant professor of psychology and principal investigator on the study. "This fits in nicely with human data and might help to explain why studies of hormone replacement therapy (HRT) do not show beneficial effects for all women. Most studies of HRT use very well-educated women. These results might spur researchers to include a broader population with a greater variation in education and socioeconomic status."

All of the mice lived in standard housing conditions that contained other mice and no toys. However, enriched mice spent three hours each day in larger cages with running wheels, tubes, and other mouse toys. The toys were varied from day to day. At 10 weeks of age, the ovaries of the mice were removed to simulate the long-term estrogen losses seen in menopause. At six months of age, the mice were then treated with estrogen or a control substance and were tested in tasks measuring spatial memory and memory for objects.

"Animals raised in standard conditions showed significant spatial and object memory improvement when treated with a high dose of estrogen, whereas memory in animals in the enriched environment were unaffected or impaired by estrogen treatment," Frick said. "Among mice not treated with estrogen, enrichment treatment alone significantly improved spatial memory. The behavioral changes were also associated with alterations in a part of the brain critical for memory. These data suggest that estrogen benefits mice raised in un-stimulating environments more than those raised in cognitively and physically stimulating env
'"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
22-Oct-2004


Page: 1 2

Related medicine news :

1. Estrogen-associated COX-2 pathways explain protection from heart disease in female mice
2. Estrogenlike drugs may eventually help postmenopausal women with weight gain
3. Estrogen offers no overall benefit for disease prevention in postmenopausal women with hysterectomy
4. Estrogen makes the brain more vulnerable to stress
5. Estrogen replacement increases risk factors for arrhythmia and sudden death
6. Estrogen may lower womens risk of heart disease by working as damper on inflammation
7. Estrogen may dictate what problem-solving strategy brain uses
8. Testosterone may reduce risk of stroke in men; Estrogen levels not related to stroke
9. Estrogens role in preventing female cardiac disease
10. Estrogen has antitumor activity in hormone therapy-resistant breast tumors
11. Estrogen shows potential as stroke treatment, UF animal studies show

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... “Vinaya” Rednam distinguishes herself once more by being among Houston’s first plastic surgeons ... the highest quality plastic surgery care without disrupting busy schedules and maintaining the ...
(Date:8/17/2017)... ... August 17, 2017 , ... Florida Hospital Zephyrhills showcased ... community partners. The newly renovated ER was designed with patients in mind and ... semi-private rooms to deliver patient results, improve efficiencies and reduce length of stay, ...
(Date:8/17/2017)... ... August 17, 2017 , ... With the introduction of new devices, new features, ... changes to the smartwatch market. As of June 2017, nearly nine percent of U.S. ... months prior. Additionally, according to latest WEAR Report Industry Overview and Forecast from NPD’s ...
(Date:8/17/2017)... ... 17, 2017 , ... Pot Valet is a leading provider of premium medical-grade ... the state, and soon, every state in the country, the company offers patients safe, ... dispensary altogether. , According to Pot Valet, all California patients have the ...
(Date:8/17/2017)... VA (PRWEB) , ... August 17, 2017 , ... ... for Great Employers , an international competition, were announced today. The awards recognize ... products and suppliers who help to create and drive great places to work. ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... CHICAGO, July 28, 2017 Hill-Rom Holdings, Inc. ... fiscal third quarter ended June 30, 2017, and updated ... For the fiscal third quarter, ... to $0.68 per diluted share in the prior-year period. ... of $0.39 per diluted share primarily related to the ...
(Date:7/27/2017)... -- West Pharmaceutical Services, Inc. (NYSE: WST ) ... and updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a ... sales at constant currency (organic) grew by 3.9%. ... to $0.60 in the prior-year quarter. Second-quarter 2017 adjusted ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
Breaking Medicine Technology:
Cached News: